Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3841-3846
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3841
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3841
Figure 3 Primary lung cancer and mediastinal metastases before and after icotinib therapy.
A: Panel 1: Ground-glass nodules in the right upper lung; Panel 2: Multiple small nodules in both lungs; Panel 3: A mass shadow in the left lower lung dorsal segment; Panel 4: Soft tissue mass shadow in the left lower hilum of lung; Panel 5: Multiple swollen lymph nodes in the mediastinum, with largest located beside the aortic arch; B and C: Multiple small pulmonary nodules gradually reduced and disappeared, mediastinal lymph node metastasis decreased and periclavicular lymph node metastasis decreased and disappeared.
- Citation: Zhai SS, Yu H, Gu TT, Li YX, Lei Y, Zhang HY, Zhen TH, Gao YG. Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib: A case report. World J Clin Cases 2020; 8(17): 3841-3846
- URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3841.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3841